Sotera Health Company (NASDAQ: SHC) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $4.6B. The Maz Rating grades it against the other companies in its sector.
Sotera Health Company's current Maz Rating and its five factor grades are for members: log in to see them.
At $16.05, Sotera Health Company trades at 26.6x trailing earnings, 3.7x sales and 6.3x book value, with an EV/EBITDA of 11.9. Over the last twelve months it generated about $1.2B of revenue and $172M of net income. It runs a gross margin of 54.4%, an operating margin of 36.0% and a net margin of 14.1%. It shows return on equity of 26.4%, return on invested capital of 8.8% and a free cash flow yield of 3.0%. On the balance sheet: a debt-to-equity ratio of 3.10 and a current ratio of 3.13. Over the past 52 weeks the share price ranged from $13.09 to $19.85, with a beta of 1.93.
Sotera Health Company does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 11 Buy and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Sotera Health Company (SHC) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 41.4% / 30% · (Cash+Inv) / Mkt Cap (36m) 7.95% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 41.4% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 7.95% / 33% · Receivables / Mkt Cap (36m) 3.99% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 41.4% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 7.95% / 33.33% · Receivables / Mkt Cap (24m) 3.99% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 65.1% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 10.9% / 33.33% · Receivables / Avg Assets (4Q) 5.74% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 63.4% / 33.33% · (Cash+ST Inv) / Total Assets 12.2% / 33.33% · (Cash+Recv) / Total Assets 18.3% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, Sotera Health Company (SHC) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Sotera Health Company is over the AAOIFI limit on Debt / Mkt Cap (36m).
Sotera Health Company reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.